Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Emergence of recombinant Mayaro virus strains from the Amazon basin.

Authors:
Carla Mavian Brittany D Rife James Jarad Dollar Eleonora Cella Massimo Ciccozzi Mattia C F Prosperi John Lednicky J Glenn Morris Ilaria Capua Marco Salemi

Sci Rep 2017 08 18;7(1):8718. Epub 2017 Aug 18.

Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.

Mayaro virus (MAYV), causative agent of Mayaro Fever, is an arbovirus transmitted by Haemagogus mosquitoes. Despite recent attention due to the identification of several cases in South and Central America and the Caribbean, limited information on MAYV evolution and epidemiology exists and represents a barrier to prevention of further spread. We present a thorough spatiotemporal evolutionary study of MAYV full-genome sequences collected over the last sixty years within South America and Haiti, revealing recent recombination events and adaptation to a broad host and vector range, including Aedes mosquito species. We employed a Bayesian phylogeography approach to characterize the emergence of recombinants in Brazil and Haiti and report evidence in favor of the putative role of human mobility in facilitating recombination among MAYV strains from geographically distinct regions. Spatiotemporal characteristics of recombination events and the emergence of this previously neglected virus in Haiti, a known hub for pathogen spread to the Americas, warrants close monitoring of MAYV infection in the immediate future.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-07152-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562835PMC
August 2017

Publication Analysis

Top Keywords

mayaro virus
8
recombination events
8
mayv
5
thorough spatiotemporal
4
report evidence
4
spread thorough
4
haiti report
4
brazil haiti
4
recombinants brazil
4
mayv full-genome
4
study mayv
4
evolutionary study
4
evidence favor
4
spatiotemporal evolutionary
4
favor putative
4
human mobility
4
epidemiology exists
4
mobility facilitating
4
evolution epidemiology
4
exists represents
4

Keyword Occurance

Similar Publications

Persistent Joint Pain Following Arthropod Virus Infections.

Authors:
Karol Suchowiecki St Patrick Reid Gary L Simon Gary S Firestein Aileen Chang

Curr Rheumatol Rep 2021 Apr 13;23(4):26. Epub 2021 Apr 13.

Department of Medicine, George Washington University, 2150 Pennsylvania Ave Suite 5-416, Washington, DC, 20037, USA.

Purpose Of Review: Persistent joint pain is a common manifestation of arthropod-borne viral infections and can cause long-term disability. We review the epidemiology, pathophysiology, diagnosis, and management of arthritogenic alphavirus infection.

Recent Findings: The global re-emergence of alphaviral outbreaks has led to an increase in virus-induced arthralgia and arthritis. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies.

Authors:
James T Earnest Autumn C Holmes Katherine Basore Matthias Mack Daved H Fremont Michael S Diamond

Cell Rep 2021 Apr;35(1):108962

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine. St. Louis, MO 63110, USA. Electronic address:

Although neutralizing monoclonal antibodies (mAbs) against epitopes within the alphavirus E2 protein can protect against infection, the functional significance of non-neutralizing mAbs is poorly understood. Here, we evaluate the activity of 13 non-neutralizing mAbs against Mayaro virus (MAYV), an emerging arthritogenic alphavirus. These mAbs bind to the MAYV virion and surface of infected cells but fail to neutralize infection in cell culture. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors.

Authors:
Lana Langendries Rana Abdelnabi Johan Neyts Leen Delang

Microorganisms 2021 Mar 31;9(4). Epub 2021 Mar 31.

Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.

Despite the emerging threat of the Mayaro virus (MAYV) in Central and South-America, there are no licensed antivirals or vaccines available for this neglected mosquito-borne virus. Here, we optimized a robust antiviral assay based on the inhibition of the cytopathogenic effect that could be used for high-throughput screening to identify MAYV inhibitors. We first evaluated different cell lines and virus inputs to determine the best conditions for a reliable and reproducible antiviral assay. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Mayaro Virus Infects Human Brain Cells and Induces a Potent Antiviral Response in Human Astrocytes.

Authors:
Michèle Bengue Pauline Ferraris Jonathan Barthelemy Cheikh Tidiane Diagne Rodolphe Hamel Florian Liégeois Antoine Nougairède Xavier de Lamballerie Yannick Simonin Julien Pompon Sara Salinas Dorothée Missé

Viruses 2021 Mar 11;13(3). Epub 2021 Mar 11.

MIVEGEC, Université de Montpellier, IRD, CNRS, 34394 Montpellier, France.

Mayaro virus (MAYV) and chikungunya virus (CHIKV) are known for their arthrotropism, but accumulating evidence shows that CHIKV infections are occasionally associated with serious neurological complications. However, little is known about the capacity of MAYV to invade the central nervous system (CNS). We show that human neural progenitors (hNPCs), pericytes and astrocytes are susceptible to MAYV infection, resulting in the production of infectious viral particles. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.

Authors:
John M Powers Nicole N Haese Michael Denton Takeshi Ando Craig Kreklywich Kiley Bonin Cassilyn E Streblow Nicholas Kreklywich Patricia Smith Rebecca Broeckel Victor DeFilippis Thomas E Morrison Mark T Heise Daniel N Streblow

PLoS Negl Trop Dis 2021 Apr 1;15(4):e0009308. Epub 2021 Apr 1.

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Mayaro virus (MAYV) is an alphavirus endemic to South and Central America associated with sporadic outbreaks in humans. MAYV infection causes severe joint and muscle pain that can persist for weeks to months. Currently, there are no approved vaccines or therapeutics to prevent MAYV infection or treat the debilitating musculoskeletal inflammatory disease. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap